跳至主要内容
临床试验/NCT00931320
NCT00931320已完成不适用

Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients

AstraZeneca0 个研究点目标入组 3,000 人开始时间: 2009年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
3,000
主要终点
Evaluate current LDL/HDL ratio in Korean patients (between baseline & after treatment)

研究概览

简要总结

An observational, non-interventional, multi-centre study to provide further information on the ratio of LDL-C to HDL-C improvement after statin treatment in Korean patients group.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects who are taking lipid-lowering medication after diagnosed as dyslipidaemia
  • Subjects who have at least made 1 visit to the outpatient clinic within previous 6 months
  • Subjects who have records of both LDL-C and HDL-C before & after statin treatment (at least four weeks after statin taking)

排除标准

  • Subjects who are unwilling or unable to provide their examination and lab result of medical chart.

结局指标

主要结局

Evaluate current LDL/HDL ratio in Korean patients (between baseline & after treatment)

时间窗: After Treatment : at least 4 weeks before statin taking /Baseline : no limitation.

次要结局

  • Evaluate difference of LDL/HDL ratio among different statins & dosages (between baseline & after treatment)(After Treatment : at least 4 weeks before statin taking / Baseline : no limitation.)

研究者

发起方
AstraZeneca
申办方类型
Industry

相似试验